Development of a humanised antibody for treatment of cancer and stroke

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1075898

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This grant explores the ability of novel monoclonal antibodies to inhibit cancer cell growth, and to prevent complications in patients with brain injuries. The results of this work will enable the development of new strategies for antibody-based therapy of many types of cancer, and improve outcomes in patients suffering from acute stroke.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2014

Funding Scheme: Development Grants

Funding Amount: $242,800.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biologically Active Molecules

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer biology | monoclonal antibody | neuroscience | receptor signalling | stroke outcome

Related Links